+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro correlates of transplant tolerance A preliminary study in liver transplant recipients



In vitro correlates of transplant tolerance A preliminary study in liver transplant recipients



Human Immunology 62(Suppl. 1): S120




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035106140

Download citation: RISBibTeXText


Related references

Frequency of donor-specific IFN-gamma-producing lymphocytes correlates with post-transplant course of liver transplant recipients. Human Immunology 63(Suppl. 1): S72, 2002

Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study. Bmc Nephrology 14: 261, 2013

Prevalence of hepatic iron overload and HFE mutations among orthotopic liver transplant recipients Preliminary results from the national hemochromatosis transplant registry. Hepatology 32(4 Pt 2): 248A, 2000

Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group. Transplantation Proceedings 28(4): 2232-2233, 1996

Post-transplant eradication of hepatitis C by pre-transplant treatment in living donor liver transplant recipients. Hepatology 34(4 Pt 2): 244A, 2001

Pre-transplant risk factors predicting post-transplant cytomegalovirus infection in liver transplant recipients. Transplant International 20(5): 419-424, 2007

In vitro intracellular IFNγ, IL-17 and IL-10 producing T cells correlates with the occurrence of post-transplant opportunistic infection in liver and kidney recipients. World Journal of Transplantation 8(1): 23-37, 2018

Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study. Journal of Clinical Pathology 66(5): 392-398, 2013

Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre. Indian Journal of Medical Microbiology 35(4): 499-503, 2018

Mechanisms of postprandial hyperglycemia in liver transplant recipients: comparison of liver transplant patients with kidney transplant patients and healthy controls. Diabetes and Metabolism 26(1): 51-56, 2000

Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States. Clinical Infectious Diseases 61(7): 1054-1062, 2015

Delay of hepatitis C recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction. Transplantation Proceedings 34(5): 1561-1562, 2002

Pre-transplant PRA in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. Journal of Heart & Lung Transplantation 21(1): 108, 2002

Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database. Liver Transplantation 18(9): 1029-1036, 2012

Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. Journal of Heart and Lung Transplantation 24(7 Suppl): S249-S254, 2005